In 2021, the WHO picked South African biotech firm Afrigen Biologics for a pilot project to give poor and middle-income countries the know-how and licenses to make COVID vaccines, in what South African President Cyril Ramaphosa then called a historic step. WHO said 69.7 per cent of the global population had received at least one dose of a COVID vaccine as of March 2023, but that figure was still below 30 per cent in low-income countries., In 2021, the WHO picked South African biotech firm Afrigen Biologics for a pilot project to give poor and middle-income countries the know-how and licenses to make COVID vaccines, in what South African President Cyril Ramaphosa then called a historic step. WHO said 69.7 per cent of the global population had received at least one dose of a COVID vaccine as of March 2023, but that figure was still below 30 per cent in low-income countries., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way